期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

脑血管痉挛的介入治疗进展 被引量：2

下载PDF
导出
摘要 脑血管痉挛（cerebral vasospasm，CVS）是动脉瘤性蛛网膜下腔出血（ Aneurysmal subarachnoid hemorrhage，aSAH）患者残疾甚至死亡的一种重要原因，其在aSAH患者中的发病率约为30％～70％［1-2］。此类患者发生延迟性神经功能缺失（ delayed ischemic neurological deficit，DIND）的几率约为30％， CVS不仅可导致局部神经功能障碍，还可导致病患功能及认知恢复障碍。故如何防治CVS是降低aSAH病患致残率和病死率的关键。早期动脉瘤的处理，脑池内血凝块的清除，早期足量全程的尼莫地平的使用、镁剂、“3H”治疗、血管内介入治疗等措施，在一定程度上改善了患者的预后［3］，尽管如此，因CVS发生比例较高，如何防治CVS仍是学者们不懈追求的目标。
作者 叶富华 周新民
机构地区 东南大学附属江阴医院神经外科
出处 《临床神经外科杂志》 CAS 2014年第6期475-478,共4页 Journal of Clinical Neurosurgery
关键词 血管内介入治疗 脑血管痉挛 动脉瘤性蛛网膜下腔出血 HEMORRHAGE cerebral 神经功能缺失 神经功能障碍 CVS
分类号 R651.1 [医药卫生—外科学]
  • 相关文献

参考文献22

  • 1Weant Kyle A, Ramsey, Christian N,et al. Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subara- chnoid hemorrhage [ J ]. Pharmacotherapy Human Pharmacology Drug Therapy ,2010,30:405.
  • 2Crowley R, Medel R, Dumont AS,et al. Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage[ J] . Stroke,2011,42:919.
  • 3Capampangan D J , Demaerschalk B M, Aguilar MI, et al. Does prophylactic postoperative hhpervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage[ J]. The Neurologist,2008,14:395.
  • 4Vatter Hartmut, Guresir Erdem, Berkefeld Joachim, et al. Perfusion- diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage [ J ]. Neurology Neurosurgery Psychiatry,2011,82 : 876.
  • 5Kimball, Matthew M, Velat Gregory J, et al. Critical care guide- lines on the endovascular management of cerebral vasospasm[ J] . Neurocritical Care ,2010,12:346.
  • 6Koenig, Matthew A. Management of delayed cerebral ischemia after subarachnoid hemorrhage [ J ]. Critical Care Neurology, 2012,18:579.
  • 7Komotar R J, zacharia BE, Otten ML, et al. Controversies in the endovascular management of cerebral vasospasm after intracranial aneurysm rupture and future directions for therapeutic approaches [ J ]. Neurosurgery ,2008,62:897.
  • 8Lioffante I, Delgodo-Mederos R, andre one V, et al. Angiograophic and hemodynamic effect of high concentrantion of intra-arterial nicardipine in cerebral vasospasm [ J ]. Neurosurgery, 2008, 63 : 1080.
  • 9Stuart RM, Helbok R, Kurtz P , et al. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachoid hemon'hage: prolonged effects on hemodynamic parameters and brain metabolism[J]. Neurosurgerv.2011.68.337.
  • 10谢丽华,张俊玲,侯玉立.法舒地尔治疗SAH后脑血管痉挛的系统评价[J].中国临床神经外科杂志,2011,16(4):200-203. 被引量：8

二级参考文献21

  • 1杨学琪,张效斌,罗晓华.观察盐酸法舒地尔治疗蛛网膜下腔出血的临床疗效[J].中国误诊学杂志,2009,9(2):299-300. 被引量：6
  • 2Julian PT Higgins, Douglas G Altman. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009.
  • 3Shibuya M, Suzuki Y, Sugita K, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Results of a prospective placebo-controlled double- blind trial [J]. J Neurosurgery, 1992, 76(4): 571-577.
  • 4Masaoka H, Takasato Y, Nojiri T, et al. Clinical effect of fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage [J]. Aeta neuroehirurgiea. Supplement, 2001, 77:209-211.
  • 5Zhao J, Zhou D, Guo J, et al. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage: results of a randomized trial of fasudil hydrochloride versus nimodipine [J]. Neurol Med Chit (Tokyo), 2006, (9): 421-427.
  • 6Ma J, Yang S, Hong G, et al. Effect of fasudil hydrochloride on cerebral vasospasm following aneurysmal subarachnoid hemorrhage in phase II clinical trial [J]. J Chin Clin Med, 2009, 4(2): 61-72.
  • 7·林.盐酸法舒地尔治疗动脉瘤性蛛网膜下腔出血后血管痉挛的临床研究[D].天津医科大学,2005.
  • 8Rembold CM. Regulation of contraction and relaxation in arterial smooth muscle [J]. Hypertension, 1992, 20: 129- 137.
  • 9Feigin VL, Rinkel GJ, Algra A, et al. Calcium antagon is in patients with aneurysmal subarachnoid hemorrhage: a systemic review [J]. Neurology, 1998, 50: 876-883.
  • 10Ferro JM, Canh~o P, Peralta R. Update on subarachnoid haemorrhage [J]. J Neurol, 2008, 255:465-479.

共引文献7

同被引文献39

  • 1Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine[ J ]. Genes Dev,2008,22 : 1276.
  • 2Benzaquen LR,Nicbolson-Weller A,Halperin JA. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet- derived growth factor from endothelial cells [ J ]. J Exp Med, 1994, 179:985.
  • 3Kasuya H, Shimizu T. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage[J]. J Neurosurg,1989, 71 : 741.
  • 4Nagata I, Zhang Z, Sawada M, et al. Systemically administered thromhin inhihitors can prevent neointimalformation and cerebral vasospasm: the possible role of thrombin and PDGF-BBin vascular pathogeneses, in Kikuchi H : ed. Strategic medical science against brain attack[ M]. Tokyo:Springer,2002:234.
  • 5Sawada M, Yanamoto H, Nagata I,et al. Prevention of neointimal formation by a serine protease inhibitor, FI3T-175, after carotid balloon injury in rats [ J ]. Stroke, 1999,30 : 644.
  • 6Yanamoto H, Kikuchi H, Okamoto S, et al. Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits[ J. Neurosurgerv, 1992,30:351.
  • 7Yanamoto H, Kikuchi H, Okamoto S : Effects of protease inhibitor and immunosuppressant on cerebral vasospasm after subarachnoid hemorrhage in rabbits [ J ]. Surg Neurol, 1994,42:382.
  • 8Zhang Z, Nagata I, Kikuchi H, et al. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage:vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB [ J ]. Stroke ,2001,32 : 1665.
  • 9Yanamoto H, Kikuchi H, Sato M, et al. Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, adminis- tered in the acute stage after suharachnoid hemorrhage [ J ]. Neurosurgery, 1992,30:358.
  • 10German JW, Gross CE, Giclas P, et al. Systemic complement depletion inhibits experimental cerebral vasospasm [ J ]. Neurosu- rgery, 1996,39 : 141.

引证文献2

临床神经外科杂志
2014年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部